Declaración de accesibilidad Saltar la navegación
  • Volver a los sitios globales
  • +44 (0)20 7454 5110
  • GDPR
  • Periodistas
  • Solicitar más información
PR Newswire: news distribution, targeting and monitoring
  • Noticias
  • Productos
  • Contacto
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Solicitar más información
    • Teléfono

    • +44 (0)20 7454 5110 de 8 AM - 5 PM GMT

    • Contáctenos
    • Contáctenos

      +44 (0)20 7454 5110
      de 8 AM - 5 PM GMT

  • Solicitar más información
  • Periodistas
  • GDPR
  • Solicitar más información
  • Periodistas
  • GDPR
  • Solicitar más información
  • Periodistas
  • GDPR
  • Solicitar más información
  • Periodistas
  • GDPR

MESI, Ltd., a company providing predictive assessment devices to healthcare professionals, has opened new offices in Germany, France and the United Kingdom in the first half of 2021
  • Deutschland - Deutsch
  • France - Français
  • USA - English
  • España - español

MESI Logo

Noticias proporcionadas por

MESI

26 may, 2021, 09:00 GMT

Compartir este artículo

Share toX

Compartir este artículo

Share toX

LJUBLJANA, Slovenia, May 26, 2021 /PRNewswire/ -- MESI, a medical device development and production company, with headquarters in Slovenia, announced the opening of new offices in Germany, France and the United Kingdom to accommodate these markets' growing demand. The expansion through local offices is one of the strategic moves to bring the MESI mTABLET predictive assessment portfolio closer to healthcare professionals.

MESI_About_us_video
MESI_About_us_video

Plans to develop MESI's own local offices were initiated by the increased demand of healthcare professionals for innovative and easy-to-use diagnostic medical devices, especially due to the rapid growth of digitalization of healthcare brought on by COVID-19. The new offices will enable the company to address the needs of healthcare professionals in each market more efficiently.

"We want to help clinicians provide better medical assessment in less time by bringing the benefits of digital and connected diagnostic devices to every single practice around the world," said Jakob Šušterič, co-founder and CEO of the company. "The new offices will support our customers to utilize the advantages of the unique concept of medical diagnostics provided by MESI mTABLET. Clinicians will receive first-class training, support and service."

The German office is lead by Dr Sebastian Winkler, who has, before joining MESI, founded and lead the German marketplace Medizintechnikmarkt.de. Sandrine Millasseau, managing director of MESI France, has been working with MESI for the last five years and will continue delivering digital innovation to French healthcare. The newest team member leading MESI UK is Martin Marsh. With his extensive experience in the medical device industry, he will be further expanding MESI presence in one of the company's most important markets.

The medical industry has recently undergone a major shift towards digitalization. MESI has been at the forefront of medical device innovation since its establishment in 2010 by launching the 1-minute Ankle-Brachial Index measuring device used for early detection of Peripheral Arterial Disease. In 2017, MESI expanded the portfolio with the MESI mTABLET, a comprehensive system of diagnostic modules, patient records and medical apps.

About the company:

MESI, Ltd. is an innovation-driven company focused on simplifying diagnostics, providing clinicians with predictive medical assessment, helping them discover diseases in the early stages and ensure all patients receive successful treatment. Our solutions fit into all medical environments, from individual practices to hospitals and home care. With strong in-house research & development and a certified production facility, we are a trustworthy provider of digital and connected diagnostic devices.

Video - https://mma.prnewswire.com/media/1518977/MESI_About_us_video.mp4
Logo - https://mma.prnewswire.com/media/1470860/MESI_Logo.jpg

Contact:

Manca Uršič Rosas
+386-51-656-292
[email protected]

Modal title

Contacte con PR Newswire

  • +44 (0)20 7454 5110
    de 8 AM - 5 PM GMT

Sitios globales

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brasil
  • Canada
  • Checo
  • Dinamarca
  • Finlandia
  • Francia
  • Alemania

 

  • India
  • Indonesia
  • Israel
  • Italia
  • México
  • Medio Oriente
  • Middle East - Arabic
  • Países Bajos
  • Noruega
  • Polonia

 

  • Portugal
  • Rusia
  • Eslovaquia
  • España
  • Suecia
  • Reino Unido
  • Estados Unidos

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contacte con PR Newswire

Sitios globales
  • Asia
  • Brasil
  • Canada
  • Checo
  • Dinamarca
  • Finlandia
  • Francia
  • Alemania
  • India
  • Israel
  • Italia
  • México
  • Medio Oriente
  • Países Bajos
  • Noruega
  • Polonia
  • Portugal
  • Rusia
  • Eslovaquia
  • España
  • Suecia
  • Reino Unido
  • Estados Unidos
+44 (0)20 7454 5110
de 8 AM - 5 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.